THE RESEARCH AND SUGGESTIONS ON THE ACCESSIBILITY OF HIGH VALUE DRUGS IN CHINA

被引：0
|
作者：
Shi, H. [1 ]
Xu, L. [1 ]
Huang, L. [1 ]
机构：
[1] Astrazeneca China, Beijing, Peoples R China
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1564
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP31
引用
收藏
页码：A657 / A657
页数：1
相关论文
共 50 条
  • [31] Diet quality and micronutrient intakes in nutritional value chains: A synthesis and suggestions for further research
    Meenakshi, J. V.
    Quisumbing, Agnes
    FOOD POLICY, 2025, 130
  • [32] Drugs' Life: Accessibility and Use of Biomedical Drugs in Myanmar
    Coderey, Celine
    SCIENCE TECHNOLOGY AND SOCIETY, 2018, 23 (02) : 234 - 251
  • [33] The power and accessibility of high-throughput methods for catalysis research
    C. Liana Allen
    David C. Leitch
    Michael S. Anson
    Matthew A. Zajac
    Nature Catalysis, 2019, 2 : 2 - 4
  • [34] The Research on Value of Financial Distress Corporation in China
    Wang, Linan
    NINTH WUHAN INTERNATIONAL CONFERENCE ON E-BUSINESS, VOLS I-III, 2010, : 1199 - 1203
  • [35] The power and accessibility of high-throughput methods for catalysis research
    Allen, C. Liana
    Leitch, David C.
    Anson, Michael S.
    Zajac, Matthew A.
    NATURE CATALYSIS, 2019, 2 (01) : 2 - 4
  • [36] IS BODY-COMPOSITION AN IMPORTANT VARIABLE IN THE PHARMACOKINETICS OF ANTICANCER DRUGS - A REVIEW AND SUGGESTIONS FOR FURTHER RESEARCH
    REILLY, JJ
    WORKMAN, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 (01) : 3 - 13
  • [37] Advances in the research of biochemical drugs in China during 1998
    Zhang, Tianmin
    Zhu, Xiqing
    Cao, Jinhua
    Zhongguo Yaoxue Zazhi/Chinese Pharmaceutical Journal, 1999, 34 (05):
  • [38] Growing research and development of targeted anticancer drugs in China
    Huang, Huiyao
    Du, Jingting
    Meng, Xinyu
    Wu, Dawei
    Yu, Yue
    Wang, Shuhang
    Wang, Lili
    Wang, Wenya
    Tang, Yu
    Li, Ning
    JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (02): : 129 - 134
  • [39] Rapid advances in research on and development of anticancer drugs in China
    Yao, Xu
    Du, Nan
    Hu, Shasha
    Wang, Lei
    Gao, Jianjun
    BIOSCIENCE TRENDS, 2019, 13 (05) : 461 - 463
  • [40] Does price negotiation in China bring high-value novel drugs to the national medical insurance beneficiaries?
    Zhu, Xingyue
    Chen, Yang
    HEALTH POLICY AND TECHNOLOGY, 2025, 14 (01)
12345